1. Инсульт: диагностика, лечение, профилактика. Под ред. З.А.Суслиной, М.А.Пирадова. М.: МЕДпресс-информ, 2009.
2. Ворлоу Ч.П., Деннис М.С., ван Гейн Ж. и др. Инсульт. Практическое руководство для ведения больных. Пер. с англ. под ред. А.А.Скоромца и В.А.Сорокоумова. СПб.: Политехника, 1998.
3. Dhamoon MS, Tai W, Boden-Albala B et al. Risk of myocardial infarction or vascular death after first ischemic stroke. Stroke 2007; 38: 1752–8.
4. Furie KL, Kasner SE, Adams RJ et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline. Stroke 2011; 42: 227–76.
5. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attacks 2008. Cerebrovasc Dis 2008; 25: 457–507.
6. Rashid R, Leonardi-Bee J, Bath Ph. Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke 2003; 34: 2741–9.
7. Schrader JS, Luders S, Kulschewski A et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention principal results of a prospective randomized controlled study (MOSES). Stroke 2005; 36: 1218–26.
8. The Heart Outcomes Prevention Evaluation Study Investigators. Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–53.
9. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–41.
10. Суслина З.А., Танашян М.М., Домашенко М.А. Антитромботическая терапия ишемических нарушений мозгового кровообращения. М.: Медицинское информационное агентство, 2009.
11. Bousser M-G. Antithrombotic agents in the prevention of ischemic stroke. Cerebrovasc Dis 2009; 27 (Suppl. 3): 12–9.
12. Практическая кардионеврология. Под ред. З.А.Суслиной, А.В.Фонякина. М.: ИМА-ПРЕСС, 2010.
13. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139–51.
14. Patel MR, Mahaffey KW, Garg J et al. Randomized, double-blind study comparing once daily oral rivaroxaban with adjusted-dose oral warfarin for the prevention of stroke in subjects with non-valvular atrial fibrillation. N Engl J Med 2011; 365: 883–91.
15. Granger CB, Alexander JH, McMurray JJ. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981–92.
16. Antithrombotic Tralists Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002; 324: 71–86.
17. Hass WK, Easton JD, Adams HP et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients: Ticlopidin Aspirin Stroke Study Group. N Engl J Med 1989; 321: 501–7.
18. Gorelick PB, Richardson D, Kelly M et al., for the African American Antiplatelet Stroke Prevention Study Investigators. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003; 289: 2947–57.
19. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329–39.
20. Bhatt DL, Flather MD, Hacke W et al. Patients with prior myocardial infarction, stroke or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007; 49: 1982–8.
21. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004; 364: 331–7.
22. Diener HC, Cunha L, Forbes C et al. European Stroke Prevention Study 2. Dipyridamol and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1–13.
23. The ESPRIT study group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischemia of arterial origin (ESPRIT): randomized controlled trial. Lancet 2006; 367: 1665–73.
24. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997; 42: 857–65.
25. Amarenco P, Labreuche J, Lavallee P, Touboul P-J. Statin in stroke prevention and carotid atherosclerosis: systematic review and meta-analysis. Stroke 2004; 35: 2902–9.
26. Amarenco P, Bogousslavsky J, Callahan A. 3rd et al., for the SPARCL investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–59.
27. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107–16.
28. Brott TG, Halperin JL, Abbara S et al. Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. J Am Coll Cardiol 2011; 57: e16–e94.
29. Liapis CD, Bell PRF, Mikhailidis D et al. ESVS Guidelines. Invasive Treatment for Carotid Stenosis: Indications, Techniques. Eur J Vasc Endovasc Surg 2009; 37: S1–S19.
30. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660–71.
31. Ringleb PA, Allenberg J, Bruckmann H et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized non-inferiority trial. Lancet 2006; 368: 1239–47.
32. Ederle J, Dobson J, Featherstone RL et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomized controlled trial. Lancet 2010; 375: 985–7.
33. Brott TG, Hobson RW 2nd, Howard G et al. CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363: 11–23.
34. Chimowitz MI, Lynn MJ, Derdeyn CP. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365: 993–1003.
35. Kasner SE, Chimowitz MI, Lynn MJ et al., for the WASID investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555–63.
36. Hackman DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke. A quantitative modeling study. Stroke 2007; 38; 1881–5.

А.В.Фонякин, Л.А.Гераскина 

Научный центр неврологии РАМН, Москва